abstract |
The present invention relates to conjugates for the treatment and diagnosis of monoclonal antibodies (MAbs) of humanized, chimeric and human anti-CD20 antibodies, in particular humanized, chimeric and human anti-CD20 antibodies, and the invention also relates to B cell lymphoma and leukemia and A method for treating various autoimmune diseases using humanized, chimeric and human anti-CD20 antibodies. n n Anti-CD20, chimeric, monoclonal antibody |